I hold a Ph.D. in Biomedical Sciences – Genetics from the Faculty of Medicine of the University of Lisbon and have 17 years of research experience in the genetics of complex diseases, with the last 10 years focused on cancer genomics. My career has been driven by a passion for unraveling the mysteries of genetic inheritance and its impact on human health. Throughout my research journey, I have been involved in cutting-edge investigations, making significant contributions to the scientific community with 18 peer-reviewed publications. As a co-inventor of eight patents currently under evaluation, I have demonstrated my ability to develop innovative solutions that address critical challenges in the field of Cancer Genetics. During my scientific career, I have participated in eight projects funded through competitive grants and secured funding as Principal Investigator (PI) for two projects funded by the Portuguese Foundation for Science and Technology (FCT), in collaboration with international teams. I am currently co-supervising a Ph.D. student, have previously supervised a postdoctoral researcher, and have mentored or co-supervised five Master’s students and seven undergraduate students. Additionally, I have lectured and served as coordinator/co-coordinator of the Oncogenetics & Oncogenomics and Clinical Oncology courses (Master’s in Oncobiology), as well as Human Genetics (Bachelor’s in Biomedical Sciences). Since 2023, I have also been delivering seminars to students in the Integrated Master’s in Medicine program. My cancer research integrates genomic, transcriptomic, and epigenomic data, leveraging bioinformatics and computational biology tools to explore the role of allelic expression imbalances in cancer risk and clinical outcomes. I have extensive expertise in next-generation sequencing (NGS) data analysis, gene expression analysis, and the functional characterization of risk variants, both in silico and in vitro. Additionally, I have a strong background in laboratory techniques, including genotyping and real-time PCR. My expertise bridges cutting-edge experimental laboratory work with advanced computational data analysis, providing a comprehensive understanding of complex biological processes. In 2022, I co-founded expressTEC, a UAlg spin-off, where I actively contribute to the company's success by overseeing the implementation of its scientific strategy. In 2024, I was part of the scientific committee that brought the International Conference of the Portuguese Association for Cancer Research (ASPIC) to the University of Algarve and Faro for the first time. I am also a member of the Scientific Committee of the Portuguese Society of Human Genetics (SPGH). Since August 2024, I have been serving as the Scientific Coordinator of CINTESIS at the University of Algarve (UAlg), overseeing research activities and fostering scientific collaboration.